ASSAY RECORD

Found 420,930 assay records

Page 21036 of 21047

Results

Showing up to 20 records.

NO.	RECORD ID	NAME	SEQUENCE	SOURCE ORGANISM	FUNCTION CATEGORY	TARGET ORGANISM	ACTIVITY	ASSAY METHOD	PMID	PATENT NO	VERIFICATION STATUS
420701	Rec_0433359	Unnamed	DEVNFLVY	synthetic construct [Synthetic]	MHC class I binding, Anticancer	HLA-B*44	>10 %	MHC class I peptide exchange binding assay	-	US20230382964A1	YES
420702	Rec_0433360	Unnamed	SVKPHLCSL	Homo sapiens [Animal]	Neoantigen, T-cell recognition (negative)	NSCLC patient CU05 T cells	-	T-cell recognition assay	-	HK40034414A	YES
420703	Rec_0433361	AP-57	KRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV	Homo sapiens [Animal]	Anticancer, Cytotoxic	Raji human B-cell lymphoma cells	-	Qualitative functional evidence	25585381	-	YES
420704	Rec_0433362	Lysozyme [109-119]	VAWRNRCKGTD	Gallus gallus [Animal]	Antioxidant	Danio rerio larvae	36.8 %	TBARS lipid peroxidation inhibition	-	-	YES
420705	Rec_0433363	Antimicrobial peptide RBP-LRR	LRRHASEGGHGPHW	Oryza sativa [Plant]	Angiogenic, Endothelial cell proliferation, Cell migration	human umbilical vein endothelial cells (HUVECs)	-	HUVEC proliferation/tube-formation/scratch-migration assays	30799089	-	YES
420706	Rec_0433364	Baceridin	WAIVLL	plant-associated Bacillus strain [Bacterium]	Anticancer, Cytotoxic	tumor cells	1-2 μg/mL	cytotoxicity assay	24692199	-	YES
420707	Rec_0433365	Baceridin	WAIVLL	plant-associated Bacillus strain [Bacterium]	Proteasome inhibitor, Enzyme inhibitory, Anticancer	proteasome	-	proteasome inhibition assay	24692199	-	YES
420708	Rec_0433366	ω-conotoxin FVIA	CKGTGKSCSRIAYNCCTGSCRSGKC	Conus fulmen [Animal]	N-type calcium channel inhibitor, Calcium channel blocker, Analgesic, Toxin, Venom	human N-type voltage-gated Ca2+ channel (CaV2.2); C2D7 (HEK293-derived) cells	11.5±1.4 nM	IC50 (whole-cell N-type Ca2+ current inhibition)	21172037	-	YES
420709	Rec_0433367	Neuropeptide B NPB29	WYKQVAGPTYYSVGRASGLLSGIRRSAYV	Oreochromis niloticus [Animal]	Feeding regulation, Hormone expression regulation, Neuropeptide	hypothalamic NPY and CCK1 expression; pituitary GH and PRL expression	-	in vivo intraperitoneal peptide injection + mRNA expression assay	24561274	CN103275204B	YES
420710	Rec_0433368	GAD65(247-266) T-cell epitope	NMYAMMIARFKMFPEVKEKG	synthetic construct [Synthetic]	T-cell epitope, Immunogenic, Autoimmune antigen, Immunomodulatory	NOD mouse splenic T cells	-	T-cell proliferation assay	7694152	-	YES
420711	Rec_0433369	5T4(97-105) T-cell epitope	FLTGNQLAV	synthetic construct [Synthetic]	T-cell epitope, Immunogenic, Tumor T-cell antigen, Immunomodulatory	T2 cells; HLA-A2-restricted CD8+ T cells	10-100 pM	4-hour cytotoxicity assay (half-maximal target lysis)	22892449	-	YES
420712	Rec_0433370	AKK24	AKKARAAKKARAAKKARAAKKARA	synthetic construct [Synthetic]	Antimicrobial, Antibacterial, Bactericidal, Membrane-disrupting	Enterococcus faecalis 2374	~1 μM	bactericidal viable-count assay	16704414	-	YES
420713	Rec_0433371	D5A	TCRVAHRGLTF	synthetic construct [Synthetic]	Antimicrobial, Antifungal, Candidacidal	Candida albicans SC5314	0.395 μM	EC50 (CFU assay)	22470523	-	YES
420714	Rec_0433372	SEQ ID NO: 419	LSELKPMSY	synthetic construct [Synthetic]	Anticancer, Tumor-associated T-cell epitope, MHC class I binding	HLA-A*01	>75 %	MHC class I peptide exchange binding assay	-	CN110785183A	YES
420715	Rec_0433373	HH307 (SEQ ID NO:307)	VRLAIRVAVIRA	synthetic construct [Synthetic]	Antimicrobial, Antibacterial	Pseudomonas aeruginosa H1001	-	4-h lux reporter killing assay (relative EC50)	-	US 9017656 B2	YES
420716	Rec_0433374	TSG009	AGSWLRDILTLLQSAL	synthetic construct [Synthetic]	Anti-infective, Antimicrobial, Antibacterial	Staphylococcus aureus ATCC 25923	1.5 μM	MIC	-	US 10351604 B2	YES
420717	Rec_0433375	HRNR2186-2207	GRHGSGSGHSSSHGQHGSGSGR	synthetic construct [Synthetic]	Antimicrobial, Antibacterial	Pseudomonas aeruginosa ATCC 10145	0.15/75 μg/mL	MBC90 (CFU assay)	-	US 2020/0115426 A1	YES
420718	Rec_0433376	HRNR2186-2207	GRHGSGSGHSSSHGQHGSGSGR	synthetic construct [Synthetic]	Antimicrobial, Antibacterial	Pseudomonas aeruginosa ATCC 10145	4.7-9.37 μg/mL	MBC100 (CFU assay)	-	US 2020/0115426 A1	YES
420719	Rec_0433377	LPRALLSSL	LPRALLSSL	synthetic construct [Synthetic]	T-cell immunogenicity, Cancer immunotherapy	HLA-B*07; human CD8+ T cells	20-49 % positive wells	in vitro T-cell immunogenicity assay (pMHC multimer flow cytometry)	-	CN110785183A; WO2019007974A1	YES
420720	Rec_0433378	Nisin Z	IXXIXLXXPGXKXGALMGXNMKXAXXNXSIHVXK	Lactococcus lactis,Streptococcus lactis [Bacterium]	Antimicrobial, Antibacterial	Staphylococcus aureus	~2 log CFU reduction	CFU reduction assay (100 mM NaCl)	16226432	-	YES